ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

116
Analysis
Health CareSouth Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
26 May 2020 17:37

A Block Deal Placement (348 Billion Won) Of Celltrion Healthcare by One Equity Partners

After the market close today, it was announced that One Equity Partners private equity firm will sell 348 billion won worth of Celltrion Healthcare...

Logo
347 Views
Share
15 Apr 2020 05:39

Biotech & Pharma Moving Up As Short Covering Continues

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 10 April 2020, the...

Logo
367 Views
Share
07 Apr 2020 03:45

Celltrion Healthcare Block Deals: Conditions, Discount, Overhang, & Arb Yield

It is now clear that neither OEP or Ion (Temasek) wants to stay at Celltrion as a long-term investor. Celltrion management reportedly asked OEP...

Logo
379 Views
Share
06 Apr 2020 19:19

Another Block Deal for Celltrion Healthcare

After the market close today, Celltrion Healthcare (091990 KS) announced that there will be a block deal worth about 272 billion won ($221 million)...

Logo
327 Views
Share
04 Apr 2020 08:20

Celltrion Pairs Trading Dynamics Checkup: Healthcare at a 2-Yr High

The Celltrion pair (Celltrion and Celltrion Healthcare) is another one ideally matched for pairs trading. As shown below, they are highly...

Logo
334 Views
Share
x